7,120
Views
47
CrossRef citations to date
0
Altmetric
Critical Review

Strategies for drug delivery to the central nervous system by systemic route

, , , &
Pages 243-257 | Received 03 Dec 2013, Accepted 21 Dec 2013, Published online: 29 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Waiting Tai & Philip Chi Lip Kwok. (2022) Recent advances in drug delivery to the central nervous system by inhalation. Expert Opinion on Drug Delivery 19:5, pages 539-558.
Read now
Marija Gvoic, Sasa Vukmirovic, Hani Al-Salami, Armin Mooranian, Momir Mikov & Karmen Stankov. (2021) Bile acids as novel enhancers of CNS targeting antitumor drugs: a comprehensive review. Pharmaceutical Development and Technology 26:6, pages 617-633.
Read now
M.D. Cayero-Otero, Maria João Gomes, Cláudia Martins, J. Álvarez-Fuentes, M. Fernández-Arévalo, B. Sarmento & L. Martín-Banderas. (2019) In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. Expert Opinion on Drug Delivery 16:12, pages 1413-1427.
Read now
Emilia Barcia, Liudmila Boeva, Luis García-García, Karla Slowing, Ana Fernández-Carballido, Yaquelyn Casanova & Sofía Negro. (2017) Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease. Drug Delivery 24:1, pages 1112-1123.
Read now
Xiao Hu, Feifei Yang, Yonghong Liao, Lin Li & Lan Zhang. (2017) Cholesterol–PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Delivery 24:1, pages 121-132.
Read now

Articles from other publishers (42)

Po Hen Lin, Chongquan Huang, Yuwei Hu, Vaibavi Srirangam Ramanujam, Ee-Soo Lee, Ruby Singh, Ulla Milbreta, Christine Cheung, Jackie Y. Ying & Sing Yian Chew. (2023) Neural cell membrane-coated DNA nanogels as a potential target-specific drug delivery tool for the central nervous system. Biomaterials 302, pages 122325.
Crossref
Wenzhe Du, Tong Wang, Shuyun Hu, Jixin Luan, Feng Tian, Guolin Ma & Jiajia Xue. (2023) Engineering of electrospun nanofiber scaffolds for repairing brain injury. Engineered Regeneration 4:3, pages 289-303.
Crossref
Avinash Kumar, Chakrawarti Prasun, Ekta Rathi, Maya S. Nair & Suvarna G. Kini. (2023) Identification of potential DNA gyrase inhibitors: virtual screening, extra-precision docking and molecular dynamics simulation study. Chemical Papers.
Crossref
Naumih M. Noah, Betty N. Mbatia & Calvin A. Omolo. 2023. Advanced Nanoformulations. Advanced Nanoformulations 685 717 .
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems 723 759 .
Ganesh Vambhurkar, Naitik Jain, Dadi A. Srinivasarao, Paras Famta, Shashi Bala Singh & Saurabh Srivastava. 2023. Polymeric Micelles: Principles, Perspectives and Practices. Polymeric Micelles: Principles, Perspectives and Practices 87 109 .
Mershen Govender, Sunaina Indermun, Pradeep Kumar & Yahya E. Choonara. 2023. Nasal Drug Delivery. Nasal Drug Delivery 83 99 .
Juliana Carolina Amorim, Andrea E. Cabrera Bermeo, Viviana E. Vásquez Urgilés, Maritza R. Martínez León & Juan M. Carpio Arévalo. (2022) An In-Silico Evaluation of Anthraquinones as Potential Inhibitors of DNA Gyrase B of Mycobacterium tuberculosis. Microorganisms 10:12, pages 2434.
Crossref
Qing Li, Xinxin Shao, Xianglin Dai, Qiong Guo, Bolei Yuan, Ying Liu & Wei Jiang. (2022) Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders. NPG Asia Materials 14:1.
Crossref
Ya Tao, Xin Zhao, XiaoPan Liu, PeiJia Wang, YinMo Huang, RuoNan Bo, MingJiang Liu & JinGui Li. (2022) Oral delivery of chitosan-coated PLGA nanoemulsion loaded with artesunate alleviates ulcerative colitis in mice. Colloids and Surfaces B: Biointerfaces 219, pages 112824.
Crossref
Mario Alonso, Emilia Barcia, Juan-Francisco González, Consuelo Montejo, Luis García-García, Mónica-Carolina Villa-Hermosilla, Sofía Negro, Ana-Isabel Fraguas-Sánchez & Ana Fernández-Carballido. (2022) Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain. Pharmaceutics 14:11, pages 2348.
Crossref
Tapan Kumar Shaw & Paramita Paul. (2022) Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor. Current Drug Delivery 19:8, pages 815-829.
Crossref
Philip Wing-Lok Ho, Eunice Eun-Seo Chang, Chi-Ting Leung, Huifang Liu, Yasine Malki, Shirley Yin-Yu Pang, Zoe Yuen-Kiu Choi, Yingmin Liang, Weng Seng Lai, Yuefei Ruan, Kenneth Mei-Yee Leung, Susan Yung, Judith Choi-Wo Mak, Michelle Hiu-Wai Kung, David B. Ramsden & Shu-Leong Ho. (2022) Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects. npj Parkinson's Disease 8:1.
Crossref
Nil Saez-Calveras & Olaf Stuve. (2022) The role of the complement system in Multiple Sclerosis: A review. Frontiers in Immunology 13.
Crossref
Magdalena Markowicz-Piasecka, Agata Markiewicz, Patrycja Darłak, Joanna Sikora, Santosh Kumar Adla, Sreelatha Bagina & Kristiina M. Huttunen. (2022) Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics. Neurotherapeutics 19:3, pages 942-976.
Crossref
Ewa Dluska, Agnieszka Markowska‐Radomska, Agata Metera, Leszek Rudniak & Konrad Kosicki. (2021) Mass transfer of anti‐cancer drug delivery to brain tumors by a multiple emulsion‐based implant. AIChE Journal 68:2.
Crossref
Nikhil Bhavsar, Bhagawati Saxena & Jigna Shah. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 31 48 .
Ajit Singh, T. Naga Mallika, Bapi Gorain, Awesh K. Yadav, Sanjay Tiwari, S.J.S. Flora, Rahul Shukla & Prashant Kesharwani. (2021) Quantum dot: Heralding a brighter future in neurodegenerative disorders. Journal of Drug Delivery Science and Technology 65, pages 102700.
Crossref
Sinaye Mhambi, David Fisher, Moise B. Tchoula Tchokonte & Admire Dube. (2021) Permeation Challenges of Drugs for Treatment of Neurological Tuberculosis and HIV and the Application of Magneto-Electric Nanoparticle Drug Delivery Systems. Pharmaceutics 13:9, pages 1479.
Crossref
Chandra Teja Uppuluri, Punna Rao Ravi & Avantika V. Dalvi. (2021) Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson’s disease. International Journal of Pharmaceutics 606, pages 120881.
Crossref
Robin Augustine, Ahmad H. Aqel, Sumama Nuthana Kalva, K.S. Joshy, Ajisha Nayeem & Anwarul Hasan. (2021) Bioengineered microfluidic blood-brain barrier models in oncology research. Translational Oncology 14:7, pages 101087.
Crossref
Alberto Carnasciali, Roberta Amoriello, Elena Bonechi, Alessio Mazzoni, Costanza Ravagli, Saer Doumett, Laura Cappiello, Mario Milco D’Elios, Giovanni Baldi & Clara Ballerini. (2020) T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology 16:2, pages 376-389.
Crossref
Fadzai P. Mutingwende, Pierre P. D. Kondiah, Philemon Ubanako, Thashree Marimuthu & Yahya E. Choonara. (2021) Advances in Nano-Enabled Platforms for the Treatment of Depression. Polymers 13:9, pages 1431.
Crossref
Rizwana Khatoon, Md Aftab Alam & Pramod Kumar Sharma. (2021) Current approaches and prospective drug targeting to brain. Journal of Drug Delivery Science and Technology 61, pages 102098.
Crossref
Elena Bellotti, Andrea L. Schilling, Steven R. Little & Paolo Decuzzi. (2021) Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review. Journal of Controlled Release 329, pages 16-35.
Crossref
Toshinobu Nishimura, Haojun Xu, Masayuki Iwasaki, Daiki Karigane, Brandon Saavedra, Yusuke Takahashi, Fabian P. Suchy, Shinichiro Monobe, Renata M. Martin, Manami Ohtaka, Mahito Nakanishi, Scott R. Burrows, Michael L. Cleary, Ravindra Majeti, Akira Shibuya & Hiromitsu Nakauchi. (2020) Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells. Gene Therapy 27:10-11, pages 525-534.
Crossref
Shima Masoudi Asil, Jyoti Ahlawat, Gileydis Guillama Barroso & Mahesh Narayan. (2020) Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials Science 8:15, pages 4109-4128.
Crossref
M.I. Teixeira, C.M. Lopes, M.H. Amaral & P.C. Costa. (2020) Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. European Journal of Pharmaceutics and Biopharmaceutics 149, pages 192-217.
Crossref
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, Rasoul Roghanian, Elham Ghasemipour Afshar, Abbas Pardakhty, Reza Mohammadinejad, Anuj Kumar & Vijay Kumar Thakur. (2020) Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines 8:1, pages 13.
Crossref
Parisa Dehghani, Vahid Jahed & Ali Zarrabi. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine 1 23 .
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics 115 127 .
Lillian M. Toomey, Carole A. Bartlett, Nikolas Gavriel, Terence McGonigle, Maimuna Majimbi, Gopana Gopalasingam, Jennifer Rodger & Melinda Fitzgerald. (2019) Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection. Scientific Reports 9:1.
Crossref
Sarah M. Carpanini, Megan Torvell & Bryan Paul Morgan. (2019) Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Frontiers in Immunology 10.
Crossref
Majid Saeedi, Masoumeh Eslamifar, Khadijeh Khezri & Solmaz Maleki Dizaj. (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomedicine & Pharmacotherapy 111, pages 666-675.
Crossref
Claire O’Connor, Nirmala Ramanath & Matthew Campbell. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery 39 56 .
Mahendra Rai, Alka Yadav, Avinsh P. Ingle, Anatoly Reshetilov, María José Blanco-Prieto & Chistiane M. Feitosa. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases 1 17 .
Mariappan Rajan, Rajendran Amarnath Praphakar & Periyakaruppan Pradeepkumar. 2019. Polymer Nanocomposites in Biomedical Engineering. Polymer Nanocomposites in Biomedical Engineering 235 270 .
Luisetto* Mauro. (2018) Amyotropyc Lateral Sclerosis and Endogenous -Esogenous Toxicological Movens: New model to verify other Pharmacological Strategies. Archives of Pathology and Clinical Research 2:1, pages 029-048.
Crossref
Melike Ekizoğlu. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors 291 315 .
Elisse C. Browne & Belinda M. Abbott. (2016) Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting. European Journal of Medicinal Chemistry 121, pages 918-925.
Crossref
Shuyan Lu & Ralph A. Nixon. 2016. Lysosomes: Biology, Diseases, and Therapeutics. Lysosomes: Biology, Diseases, and Therapeutics 315 356 .
Md. Lutful Amin, Jae Yeon Joo, Dong Kee Yi & Seong Soo A. An. (2015) Surface modification and local orientations of surface molecules in nanotherapeutics. Journal of Controlled Release 207, pages 131-142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.